According to VectivBio's latest financial reports the company's current EPS (TTM) is -$2.12. In 2022 the company made an earnings per share (EPS) of -$2.12 an increase over its 2021 EPS that were of -$3.23.
Year | EPS | Change |
---|---|---|
2022 | -$2.12 | -34.37% |
2021 | -$3.23 | -48.24% |
2020 | -$6.24 | 155.11% |
2019 | -$2.45 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$2.06 | -2.83% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$6.20 | 192.45% | ๐ฌ๐ง UK |
Novavax NVAX | -$7.19 | 239.15% | ๐บ๐ธ USA |
Novocure
NVCR | -$1.86 | -12.26% | Jersey |